Skip to main content

Honest Comparison · June 2026

REMEVi vs. Gimme Care

Gimme Care advertises a lower headline price. REMEVi is built for native bilingual care, a dedicated coordinator, all-50-states licensing, and fast support. Here's exactly what we found — no spin.

Side-by-side

REMEVi vs. Gimme Care feature by feature

Based on publicly available data, pricing pages, and patient reviews — June 2026.

Feature REMEVi Gimme Care
Semaglutide — lowest advertised ✅ $199/mo (52-wk) · $279/mo monthly — all-inclusive ~$130/mo (3-mo plan) · ~$160/mo monthly
Tirzepatide — lowest advertised ✅ $269/mo (52-wk) · $379/mo monthly ~$163/mo (3-mo plan) · ~$199/mo monthly
Lowest price requires long prepay? ✅ No — monthly option, cancel anytime ⚠️ Lowest price needs a 3-month plan
Separate membership fee ✅ None — care, meds & shipping bundled ✅ None
Spanish-language support ✅ Fully bilingual (built-in) ❌ No Spanish support found (Jun 2026)
Bilingual care coordinator ✅ Assigned to every patient ❌ Not offered
LegitScript certified ✅ Certified ✅ Certified
All-inclusive price ✅ Yes — one all-inclusive price ✅ Yes

Pricing and features subject to change. Always verify current pricing on each provider's website.

The bilingual difference

Built bilingual — not retrofitted

We did not find Spanish-language support advertised by Gimme Care as of June 2026. REMEVi was built bilingual from the ground up. Every intake form, provider note, care coordinator message, and patient touchpoint is available in fluent English and Spanish.

Bilingual intake forms
Complete your intake in English or Spanish — both are native, not translated.
Spanish-speaking care teams
Your assigned care coordinator speaks your language fluently.
Bilingual medication instructions
All dosing guides and safety info provided in both languages.

GLP-1 programs

How the GLP-1 programs compare

Both REMEVi and Gimme Care offer compounded semaglutide and tirzepatide for weight loss. The active pharmaceutical ingredients are the same — what differs is the experience around the medication: pricing structure, care team access, language support, response time, and where the provider is licensed to treat you.

On pricing: Let's be candid — Gimme Care advertises a lower headline price, roughly $130/month for semaglutide and roughly $163/month for tirzepatide, with its lowest prices tied to a 3-month plan. REMEVi's semaglutide starts at $199/month on a 52-week plan ($279/month monthly) and tirzepatide at $269/month on a 52-week plan ($379/month monthly), available month-to-month with no long prepay required. Always verify current pricing directly on each provider's site, as telehealth pricing changes frequently.

On language: This is where the platforms diverge. We did not find Spanish-language support advertised by Gimme Care as of June 2026. REMEVi's entire platform — intake forms, clinical summaries, medication instructions, care coordinator communications — is available natively in English and Spanish. For the 62 million Spanish-speaking Americans, this is not a minor feature. It is a fundamental difference in the quality of care they receive.

On support: REMEVi assigns every patient a dedicated bilingual care coordinator with a 2-hour response target. For patients managing side effects, dosage questions, or medication concerns, fast human support in your own language matters significantly.

On clinical oversight and coverage: Both platforms use licensed US providers for prescribing, and both are LegitScript certified. REMEVi is licensed across all 50 states plus DC, with providers licensed in the patient's specific state. Prescription approval typically occurs within 24 hours. If Spanish-language care and dedicated, fast support matter to you, REMEVi is built for that.

FAQ

Common questions

Yes — especially if Spanish-language care and dedicated, fast support matter to you. REMEVi is built natively bilingual in English and Spanish, assigns every patient a bilingual care coordinator, is licensed across all 50 states plus DC, and targets a 2-hour support response. Gimme Care advertises a lower headline price, so compare the full picture: what you pay, the support you get, and the language you receive care in.

Gimme Care advertises lower headline prices — roughly $130/month for semaglutide and roughly $163/month for tirzepatide, with the lowest prices tied to a 3-month plan. REMEVi's semaglutide starts at $199/month on a 52-week plan ($279/month monthly) and tirzepatide at $269/month on a 52-week plan ($379/month monthly). REMEVi's price is one all-inclusive number that bundles native bilingual care, nationwide licensing, a dedicated care coordinator, and faster support. Always verify current pricing on each provider's website, as telehealth pricing changes frequently.

We did not find Spanish-language support advertised by Gimme Care as of June 2026 — please verify directly with them. REMEVi is natively bilingual: every intake form, care coordinator message, clinical summary, and medication instruction is available in fluent English and Spanish from day one.

Gimme Care advertises a lower headline price, and that may be the right fit for some patients. REMEVi is built for people who value native bilingual English/Spanish care, a dedicated bilingual care coordinator on every account, licensing across all 50 states plus DC, a 2-hour response target, and one transparent all-inclusive price with no separate membership fee. If Spanish-language care and dedicated, fast support matter to you, REMEVi is built for that.

Both REMEVi and Gimme Care are LegitScript certified, which is a meaningful signal of legitimacy for telehealth and online pharmacy services. REMEVi adds licensing across all 50 states plus DC and natively bilingual care, so patients receive care from providers licensed in their specific state, in English or Spanish. Compare both on the trust factors that matter most to you.

Yes. Switching is straightforward — complete REMEVi's 5-minute intake form, a clinician reviews your case within 24 hours, and your medication ships within days. You do not need to formally cancel Gimme Care before starting with REMEVi; simply time your transition to avoid overlapping charges. Both REMEVi and Gimme Care offer compounded semaglutide and compounded tirzepatide prescribed by licensed US providers and prepared by state-licensed compounding pharmacies. Compounded medications are non-FDA-approved preparations prepared by state-licensed compounding pharmacies and are not generic versions of, nor the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.

Ready to get started with REMEVi?

Clinical review in 24 hours. No insurance needed. From $199/mo on 52-week plan, all-inclusive — bilingual care included.

Start free consultation
From $199/mo · 52-wk plan Check eligibility →

No insurance required · Cancel anytime